Skip to main content

Table 1 Funding distribution by research activity for United Kingdom Health Research Analyses in 2004/2005, 2009/2010 and 2014

From: United Kingdom health research analyses and the benefits of shared data

HRCS Research Activity Group 2004/2005 2009/2010 2014 (HRAF) Difference in 2014 (£) Difference in 2014 (%)
Value (£m) % Value (£m) % Value (£m) % vs. 04/05 vs. 09/10 vs. 04/05 vs. 09/10
1 Underpinning 401.7 33.6% 488.7 27.6% 453.5 23.9% 51.8 –35.2 –9.7% –3.7%
2 Aetiology 414.4 34.7% 563.1 31.8% 558.4 29.4% 144. –4.7 –5.2% –2.3%
3 Prevention 29.6 2.5% 66.4 3.7% 101.5 5.4% 71.9 35.2 2.9% 1.6%
4 Detection and Diagnosis 62.9 5.3% 129.9 7.3% 189.0 10.0% 126.1 59.1 4.7% 2.6%
5 Treatment Development 102.9 8.6% 189.3 10.7% 228.8 12.1% 126.0 39.6 3.5% 1.4%
6 Treatment Evaluation 99.0 8.3% 151.5 8.5% 179.0 9.4% 79.9 27.5 1.1% 0.9%
7 Disease Management 27.7 2.3% 57.3 3.2% 71.4 3.8% 43.7 14.1 1.4% 0.5%
8 Health Services 56.2 4.7% 126.1 7.1% 114.9 6.1% 58.7 –11.2 1.4% –1.1%
Grand Total 1194.3 100% 1772.3 100% 1896.5 100% 702.1 124.2 0.0% 0.0%
  1. Note (Table 1 and Figure 1): The 2004/2005 analysis did not include Arthritis Research UK, so data from this charity was added retrospectively in comparisons in the 2009/2010 analysis. The 2014 analysis included contributions from 64 research organisations, however, to allow comparable data with previous analyses, only the Health Research Analysis Forum (HRAF) group funders (original 11 plus Arthritis Research UK) are included here. Award values are in 2014 real terms, extrapolated from original spend using GDP deflator data as of December 2014. See the United Kingdom Health Research Analysis 2014 main report for more details